Trial Profile
Cross-sectional survey on patients experience with suvorexant and other hypnotics in insomnia patients with nocturia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Jul 2019
Price :
$35
*
At a glance
- Drugs Suvorexant (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- Sponsors MSD KK
- 16 Jul 2019 Status has been changed to completed.
- 17 Jan 2018 New trial record